137 related articles for article (PubMed ID: 22520478)
21. Primary and secondary therapeutic strategies for EGF receptor pathway inhibition in non-small-cell lung cancer.
Batus M; Fidler MJ; Bonomi PD
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1589-99. PubMed ID: 20942630
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy.
Savonarola A; Palmirotta R; Guadagni F; Silvestris F
Pharmacogenomics J; 2012 Aug; 12(4):277-86. PubMed ID: 22760589
[TBL] [Abstract][Full Text] [Related]
23. Advances in treatment of lung cancer with targeted therapy.
Cagle PT; Chirieac LR
Arch Pathol Lab Med; 2012 May; 136(5):504-9. PubMed ID: 22540298
[TBL] [Abstract][Full Text] [Related]
24. Lung cancer biomarkers: present status and future developments.
Cagle PT; Allen TC; Olsen RJ
Arch Pathol Lab Med; 2013 Sep; 137(9):1191-8. PubMed ID: 23991729
[TBL] [Abstract][Full Text] [Related]
25. The surgeon's role in molecular biology.
Rocco G
J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S18-22. PubMed ID: 22739075
[TBL] [Abstract][Full Text] [Related]
26. Molecular targeted therapy in lung cancer.
Fujioka N; Bitterman PB
Minn Med; 2012 Oct; 95(10):38-41. PubMed ID: 23193704
[TBL] [Abstract][Full Text] [Related]
27. Genes and pathology of non-small cell lung carcinoma.
Sakashita S; Sakashita M; Sound Tsao M
Semin Oncol; 2014 Feb; 41(1):28-39. PubMed ID: 24565579
[TBL] [Abstract][Full Text] [Related]
28. Biomarker testing in non-small cell lung cancer: a clinician's perspective.
Bernicker E
Arch Pathol Lab Med; 2015 Apr; 139(4):448-50. PubMed ID: 25166873
[No Abstract] [Full Text] [Related]
29. A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization.
Hensing T; Chawla A; Batra R; Salgia R
Adv Exp Med Biol; 2014; 799():85-117. PubMed ID: 24292963
[TBL] [Abstract][Full Text] [Related]
30. Molecular diagnostics and personalized medicine in oncology: challenges and opportunities.
Normanno N; Rachiglio AM; Roma C; Fenizia F; Esposito C; Pasquale R; La Porta ML; Iannaccone A; Micheli F; Santangelo M; Bergantino F; Costantini S; De Luca A
J Cell Biochem; 2013 Mar; 114(3):514-24. PubMed ID: 22991232
[TBL] [Abstract][Full Text] [Related]
31. A systematic approach to the development of novel therapeutics for lung cancer using genomic analyses.
Daigo Y; Takano A; Teramoto K; Chung S; Nakamura Y
Clin Pharmacol Ther; 2013 Aug; 94(2):218-23. PubMed ID: 23657161
[TBL] [Abstract][Full Text] [Related]
32. Targeted therapy for lung cancer: present and future.
Aggarwal C
Ann Palliat Med; 2014 Jul; 3(3):229-35. PubMed ID: 25841697
[TBL] [Abstract][Full Text] [Related]
33. Emerging targets in advanced non-small-cell lung cancer.
Valentino F; Borra G; Allione P; Rossi L
Future Oncol; 2018 Jun; 14(13s):61-72. PubMed ID: 29989453
[TBL] [Abstract][Full Text] [Related]
34. Precision medicine in oncology standard of care.
Adams L
Semin Oncol Nurs; 2014 May; 30(2):100-8. PubMed ID: 24794083
[TBL] [Abstract][Full Text] [Related]
35. The paradigm of personalized therapy in oncology.
Gasparini G; Longo R
Expert Opin Ther Targets; 2012 Mar; 16 Suppl 1():S7-16. PubMed ID: 22073968
[TBL] [Abstract][Full Text] [Related]
36. Personalizing oncology: perspectives and prospects.
Mendelsohn J
J Clin Oncol; 2013 May; 31(15):1904-11. PubMed ID: 23589547
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic challenges in non-small-cell lung cancer: an integrated medicine approach.
Salgia R
Future Oncol; 2015; 11(3):489-500. PubMed ID: 25675128
[TBL] [Abstract][Full Text] [Related]
38. [The targets research of non-small cell lung cancer targeted therapy].
Xue H; Zhou S; Lu W; Zhao Z
Zhongguo Fei Ai Za Zhi; 2013 Feb; 16(2):107-13. PubMed ID: 23425904
[No Abstract] [Full Text] [Related]
39. [Advances of driver gene and targeted therapy of non-small cell lung cancer].
Zhang D; Huang Y; Wang H
Zhongguo Fei Ai Za Zhi; 2014 Oct; 17(10):750-4. PubMed ID: 25342042
[TBL] [Abstract][Full Text] [Related]
40. Targeting castration-resistant prostate cancer with monoclonal antibodies and constructs.
Slovin SF
Immunotherapy; 2013 Dec; 5(12):1347-55. PubMed ID: 24283845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
